Managers / Q3 2025 · view latest →
North Growth Management Ltd.
CIK 0001745796 · SUITE 830 - 505 BURRARD ST., BOX 56, VANCOUVER, A1, V7X1M4 · 6046885440
Summary
North Growth Management Ltd. reported $574M in U.S.-listed holdings across 47 positions for Q3 2025.
Its largest position, CIEN, represents 8.2% of the portfolio.
The book was largely unchanged from Q2 2025.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 100.0% · $574M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| AZOAUTOZONE | ADDED | +1.0K | 2.0K | +$5M | $10M |
| TMOTHERMO FISHER SCIENTIFIC | ADDED | +6.0K | 21.0K | +$4M | $10M |
| ALGNALIGN TECHNOLOGY | ADDED | +12.0K | 45.0K | −$547,000 | $6M |
| IQVIQVIA | ADDED | +11.0K | 44.0K | +$3M | $8M |
| LITELUMENTUM | TRIMMED | −64.0K | 152.0K | +$4M | $25M |
| URIUNITED RENTALS | ADDED | +2.0K | 11.0K | +$4M | $10M |
| CIENCIENA | TRIMMED | −82.0K | 325.0K | +$14M | $47M |
| COHRCOHERENT | TRIMMED | −49.0K | 200.0K | −$692,000 | $22M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $653M | 47 | Apr 24, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $639M | 47 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $574M | 47 | Oct 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $533M | 47 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $474M | 47 | Apr 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $527M | 46 | Jan 28, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $537M | 48 | Nov 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $506M | 46 | Jul 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $524M | 47 | Apr 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $469M | 47 | Feb 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $451M | 49 | Oct 19, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $487M | 48 | Jul 20, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $469M | 46 | May 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $440M | 45 | Feb 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $401M | 46 | Oct 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $431M | 47 | Jul 18, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $541M | 51 | Apr 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $602M | 49 | Feb 7, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $567M | 50 | Oct 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $615M | 50 | Jul 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $564M | 50 | May 7, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $488M | 47 | Feb 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $455M | 47 | Nov 4, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $417M | 48 | Aug 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $356M | 47 | May 8, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $446M | 45 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $414M | 46 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $404M | 46 | Aug 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $374M | 42 | May 10, 2019 | RESTATEMENT | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.